Showing 109 to 120 of 156 results
Late Eating Linked to Impaired Glucose Tolerance and Weight Management
Studies reveal a strong link between late meal timing and impaired glucose tolerance, independent of diet composition or weight. Research by Garaulet and the UOC-Columbia team demonstrated that eating after 3 PM hinders weight loss, and consuming a significant portion of daily calories after 5 PM in...
Late Eating Linked to Impaired Glucose Tolerance and Weight Management
Studies reveal a strong link between late meal timing and impaired glucose tolerance, independent of diet composition or weight. Research by Garaulet and the UOC-Columbia team demonstrated that eating after 3 PM hinders weight loss, and consuming a significant portion of daily calories after 5 PM in...
Progress
40% Bias Score
Obesity Vaccine Shows Promise in Mice, Preventing Weight Gain from Unhealthy Diets
Scientists developed a vaccine using Mycobacterium vaccae bacteria that prevents weight gain in mice fed a high-fat, high-sugar diet; this contrasts with Ozempic's appetite-reducing mechanism.
Obesity Vaccine Shows Promise in Mice, Preventing Weight Gain from Unhealthy Diets
Scientists developed a vaccine using Mycobacterium vaccae bacteria that prevents weight gain in mice fed a high-fat, high-sugar diet; this contrasts with Ozempic's appetite-reducing mechanism.
Progress
48% Bias Score
AI-Powered Dietary Study to Reveal Personalized Weight Management Strategies in 2025
A major US study analyzing data from over 8,000 adults will publish initial results in early 2025, utilizing AI to analyze genetic factors, gut microbiome, lifestyle, and prior illnesses to improve predictions of individual responses to diets and long-term dietary changes.
AI-Powered Dietary Study to Reveal Personalized Weight Management Strategies in 2025
A major US study analyzing data from over 8,000 adults will publish initial results in early 2025, utilizing AI to analyze genetic factors, gut microbiome, lifestyle, and prior illnesses to improve predictions of individual responses to diets and long-term dietary changes.
Progress
40% Bias Score
Proposed Sugary Drinks Tax Aims to Curb Australia's Obesity Crisis
Australia's high rates of obesity and type 2 diabetes, linked to excessive sugar consumption, could be mitigated by a proposed sugary drinks tax estimated to generate $500 million annually while reducing healthcare costs and sugar intake.
Proposed Sugary Drinks Tax Aims to Curb Australia's Obesity Crisis
Australia's high rates of obesity and type 2 diabetes, linked to excessive sugar consumption, could be mitigated by a proposed sugary drinks tax estimated to generate $500 million annually while reducing healthcare costs and sugar intake.
Progress
56% Bias Score
Online Pharmacies Exploit Loopholes, Fueling Easy Access to Weight-Loss Injections
Andy King, denied NHS weight-loss jabs, found numerous online pharmacies offering discounted injections, highlighting loopholes in regulations promoting prescription-only medications, raising concerns about easy access and potential misuse.
Online Pharmacies Exploit Loopholes, Fueling Easy Access to Weight-Loss Injections
Andy King, denied NHS weight-loss jabs, found numerous online pharmacies offering discounted injections, highlighting loopholes in regulations promoting prescription-only medications, raising concerns about easy access and potential misuse.
Progress
48% Bias Score
Brain's Control of Intestinal Fat Absorption Suggests New Obesity Treatments
Researchers in Shanghai discovered that the brain regulates intestinal fat absorption in mice by controlling the length of microvilli in the jejunum via the vagus nerve; inactivating the nerve's dorsal motor nucleus reduces fat absorption and weight, while activation increases it, suggesting potenti...
Brain's Control of Intestinal Fat Absorption Suggests New Obesity Treatments
Researchers in Shanghai discovered that the brain regulates intestinal fat absorption in mice by controlling the length of microvilli in the jejunum via the vagus nerve; inactivating the nerve's dorsal motor nucleus reduces fat absorption and weight, while activation increases it, suggesting potenti...
Progress
36% Bias Score
NHS Weight-Loss Jab: High Cost Limits Access for Millions
Ray, 62, lost over two stone in five months using Wegovy via the NHS, but limited funding means only a tiny percentage of the 3.4 million eligible patients in England can access such treatments; the annual cost per patient is around £3,000.
NHS Weight-Loss Jab: High Cost Limits Access for Millions
Ray, 62, lost over two stone in five months using Wegovy via the NHS, but limited funding means only a tiny percentage of the 3.4 million eligible patients in England can access such treatments; the annual cost per patient is around £3,000.
Progress
52% Bias Score
BBVA Award Recognizes GLP-1 Hormone Discoverers for Diabetes, Obesity Treatments
The BBVA Foundation Frontiers of Knowledge Award in Biomedicine was given to four researchers for their discovery of the GLP-1 hormone's role in glucose regulation, appetite, and its implications for treating type 2 diabetes, obesity, and neurodegenerative diseases.
BBVA Award Recognizes GLP-1 Hormone Discoverers for Diabetes, Obesity Treatments
The BBVA Foundation Frontiers of Knowledge Award in Biomedicine was given to four researchers for their discovery of the GLP-1 hormone's role in glucose regulation, appetite, and its implications for treating type 2 diabetes, obesity, and neurodegenerative diseases.
Progress
32% Bias Score
US Nutrition Policy: State Initiatives vs. Federal Budget Cuts
The incoming US administration's focus on chronic disease prevention through nutrition is driving state-level Medicaid waiver proposals for improved food access and education, but proposed federal budget cuts threaten to reverse this progress.
US Nutrition Policy: State Initiatives vs. Federal Budget Cuts
The incoming US administration's focus on chronic disease prevention through nutrition is driving state-level Medicaid waiver proposals for improved food access and education, but proposed federal budget cuts threaten to reverse this progress.
Progress
36% Bias Score
NHS Wait Times Fuel Unsafe Online Weight-Loss Drug Purchases
Britain's top GP warns that long waits for NHS weight-loss services are driving people to buy potentially unsafe drugs online, as some patients face up to five-year waits for specialist support, while the NHS rollout of Mounjaro, a key weight-loss jab, is scheduled for 12 years, impacting an estimat...
NHS Wait Times Fuel Unsafe Online Weight-Loss Drug Purchases
Britain's top GP warns that long waits for NHS weight-loss services are driving people to buy potentially unsafe drugs online, as some patients face up to five-year waits for specialist support, while the NHS rollout of Mounjaro, a key weight-loss jab, is scheduled for 12 years, impacting an estimat...
Progress
48% Bias Score
Global Diabetes Cases Double Since 1990, Underscoring Treatment Gaps
A new Lancet study reveals over 800 million people globally have diabetes—double the 1990 figure—with the largest increases in low- and middle-income countries due to lifestyle changes and limited treatment access; resulting in over 445 million untreated adults in 2022.
Global Diabetes Cases Double Since 1990, Underscoring Treatment Gaps
A new Lancet study reveals over 800 million people globally have diabetes—double the 1990 figure—with the largest increases in low- and middle-income countries due to lifestyle changes and limited treatment access; resulting in over 445 million untreated adults in 2022.
Progress
36% Bias Score
FDA Approves First Prescription Drug for Obstructive Sleep Apnea
The FDA approved Zepbound, a GLP-1 receptor agonist, as the first prescription drug for moderate-to-severe obstructive sleep apnea in obese patients; clinical trials showed significant improvements in breathing disruptions and weight loss (18-20%), potentially impacting the 30 million Americans with...
FDA Approves First Prescription Drug for Obstructive Sleep Apnea
The FDA approved Zepbound, a GLP-1 receptor agonist, as the first prescription drug for moderate-to-severe obstructive sleep apnea in obese patients; clinical trials showed significant improvements in breathing disruptions and weight loss (18-20%), potentially impacting the 30 million Americans with...
Progress
44% Bias Score
Showing 109 to 120 of 156 results